Physician profile
Deane E Smith
NPI 1457677148
$7,178.26
in general payments reported to CMS, 2019-2025
10 companies · $27.59 in 2025
The $27.59 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,804 · 2020: $177 · 2021: $514 · 2022: $602 · 2023: $2,904 · 2024: $150 · 2025: $27.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,603 · Food and Beverage: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,603.00 |
| Food and Beverage | $1,478.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,684.44 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $1,932.75 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $1,178.37 | 2019 | |
| Edwards Lifesciences Corporation | $566.49 | 2019-2023 | |
| Atricure, INC. | $357.36 | 2019-2020 | |
| Artivion, INC. | $212.91 | 2021 | |
| Bolton Medical INC | $146.50 | 2019 | |
| Baxter Healthcare | $60.91 | 2022-2023 | Floseal |
| Cvrx, INC. | $27.59 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deane Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.